Human B Lymphotropic Virus (HBLV) Isolation And Products
Description of Invention:
This invention concerns the isolation of a new human virus, originally called Human B Lymphotropic Virus (HBLV), now known as Human Herpes Virus Type 6 (HHV-6). HHV-6 causes the common childhood disease roseola. It has been linked to other diseases in persons in an immune deficient state, including those who are HIV infected. Recently it has been linked to multiple sclerosis. The claims cover the virus itself, nucleic acid sequences from the virus and proteins they encode, cell cultures infected with the virus, and detection of the virus by DNA hybridization and immunoassay means.
Inventors:
SZ Salahuddin (NCI) DV Ablashi (NCI) SF Josephs (NCI) WC Saxinger (NCI) F Wong-Staal (NCI) RC Gallo (NCI)
Patent Status:
DHHS Reference No. E-454-1986/3 --
U.S. Patent 5,604,093 issued 18 Feb 1997
U.S. Patent 6,054,283 issued 25 Apr 2000
U.S. Patent 6,018,027 issued 25 Jan 2000
For Additional Information Please Contact: Cristina Thalhammer-Reyero PhD MBA
NIH Office of Technology Transfer
6011 Executive Blvd, Suite 325
Rockville, MD 20852-3804
Phone: (301) 435-4507
Email: thalhamc@mail.nih.gov
Fax: (301) 402-0220
